Articles by Industry Expert

Controlling Care Costs for Chronic Kidney Disease

By Julie Schulz MD MPH – In addition to being one of the top 10 causes of death in the United States, chronic kidney disease is a significant driver of cost for commercial insurance and Medicare. However, significant costs can be avoided with earlier detection, better quality care, and aligned physician incentives.






A Sea-Change is Coming in How Laboratory-Developed Tests are Regulated – Is your Lab Ready?

By Inga Rose & and Aaron Schlum – On May 6, FDA published a final rule that will change the way laboratory-developed tests are regulated. The rule phases out the agency’s general policy of “enforcement discretion” and mandates that, across five stages within the next four years, LDTs will be beholden to the same regulatory requirements as in vitro diagnostics.


Can AI Improve De-identification of PHI?

By Zac Amos – Healthcare providers and information technology teams tirelessly safeguard systems against cyberattacks and preserve patients’ privacy. De-identification, one of their best defenses, has long been a staple in the industry, as HIPAA requires.


Value Based Care Musings

By Matt Fisher – Value based care has become an evergreen topic in healthcare circles with the accompanying message that value based care will transform healthcare. Is that transformation happening? Is the value based care discussion stagnating or getting stuck on certain concepts?